Provided by Tiger Trade Technology Pte. Ltd.

Trendlines

0.053
+0.0011.92%
Volume:1.06M
Turnover:56.44K
Market Cap:77.12M
PE:7.59
High:0.055
Open:0.053
Low:0.053
Close:0.052
52wk High:0.084
52wk Low:0.029
Shares:1.46B
Float Shares:622.00M
Volume Ratio:0.98
T/O Rate:0.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.007
EPS(LYR):0.002
ROE:9.62%
ROA:5.39%
PB:0.72
PE(LYR):25.42

Loading ...

Trendlines Group's ElastiMed Expands Medical Wearables to US Market; Shares Drop 2%

MT Newswires
·
May 19

BRIEF-Trendlines Group Says Elastimed Enters Strategic U.S. Distribution Agreement

Reuters
·
May 19

Trendlines portfolio firm ElastiMed signs US distribution deal for MyoSleeve device

Reuters
·
May 18

Trendlines Group - U.S. Partner to Distribute Elastimed's FDA-Cleared Myosleeve Device

THOMSON REUTERS
·
May 18

Trendlines Group - Agreement Includes Minimum Purchase Commitments and Growth Support for Elastimed

THOMSON REUTERS
·
May 18

Trendlines Group - Elastimed Enters Strategic U.S. Distribution Agreement for Wearable Compression Device

THOMSON REUTERS
·
May 18

Trendlines answers shareholder questions ahead of April 16 AGM

Reuters
·
May 14

Trendlines, Controlling Shareholder to Invest Combined $1.4 Million in Portfolio Firms

MT Newswires
·
May 12

Trendlines says LH related firms invest USD 600,000 in Vensica round

Reuters
·
May 11

The Trendlines Drug Secures US FDA Nod for Phase 2 Bladder Treatment Trial; Shares Surge 5%

MT Newswires
·
May 05

Trendlines portfolio company Vensica wins FDA IND clearance for Phase 2 OAB trial

Reuters
·
May 04

Trendlines portfolio firm Celleste unveils milk chocolate bars using cell-cultured cocoa butter

Reuters
·
Apr 21

Trendlines Group held special general meeting

Reuters
·
Apr 16

Trendlines Group held annual general meeting, re-elected two directors

Reuters
·
Apr 16

Celleste Bio unveils milk chocolate bars made with cell-cultured cocoa butter

Reuters
·
Apr 16

Trendlines publishes FY2025 annual report

Reuters
·
Apr 01

Trendlines affiliate Seger Surgical Solutions completes three first-in-human cases for laparoscopic bowel closure device

Reuters
·
Mar 17

Trendlines affiliate IBI Ag completes AI-driven de novo protein bioinsecticide platform proof of concept

Reuters
·
Mar 12

the Trendlines Group Ltd. Press Release - Ibi Ag Announces AI-Driven De Novo Protein Design Bioinsecticides Platform

THOMSON REUTERS
·
Mar 12

Trendlines Group Ltd. Publishes FY2025 Annual Report

Reuters
·
Mar 11